This is a competitive renewal for a grant that provided the first molecular description of an MHC class I-specific inhibitory receptor (Ly49A) on natural killer (NK) cells which constitute the third major lymphocyte population. Like other lymphocytes, NK cells play significant roles in host defense against tumors and invading pathogens. Humans with selective NK cell deficiencies suffer from recurrent viral and bacterial infections. However, the in vivo development of NK cells is poorly understood. In the last granting period, the investigator's laboratory made significant progress in their specific aims to detail the interactions between Ly49A and its MHC class I ligand. But while producing a Ly49A transgenic mouse as proposed, they generated a mouse that is selectively deficient in NK cells. Unrelated to the function of Ly49A as an inhibitory receptor, these mice appear to have an arrest in NK cell development at an intermediate stage of maturation that is present in wild type mice. Both subpopulations of NK cells are defective in production of IFNgamma. Furthermore, they determined that the transgenic construct is inserted in a gene for a transcription factor. The principal investigator and his laboratory therefore request to focus their efforts in this renewal on the study of NK cell development in vivo. They propose to analyze the transgenic NK cells and their corresponding stage in wild type mice with respect to gene expression, functional responses to cytokines, and their signaling pathways. They will evaluate the role of the transcription factor in NK cell maturation, and investigate other NK cell deficiencies that arise from mutations in transcription factors. These studies will provide significant insight into NK cell development.
| Sojka, Dorothy K; Plougastel-Douglas, Beatrice; Yang, Liping et al. (2014) Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. Elife 3:e01659 |
| Ebihara, Takashi; Jonsson, A Helena; Yokoyama, Wayne M (2013) Natural killer cell licensing in mice with inducible expression of MHC class I. Proc Natl Acad Sci U S A 110:E4232-7 |
| Fogel, Leslie A; Yokoyama, Wayne M; French, Anthony R (2013) Natural killer cells in human autoimmune disorders. Arthritis Res Ther 15:216 |
| Peng, Hui; Jiang, Xiaojun; Chen, Yonglin et al. (2013) Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J Clin Invest 123:1444-56 |
| Choi, Taewoong; Ferris, Stephen T; Matsumoto, Naoki et al. (2011) Ly49-dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands. J Immunol 186:3911-7 |
| Elliott, Julie M; Yokoyama, Wayne M (2011) Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol 32:364-72 |
| Vivier, Eric; Raulet, David H; Moretta, Alessandro et al. (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331:44-9 |
| Vargas, Claudia L; Poursine-Laurent, Jennifer; Yang, Liping et al. (2011) Development of thymic NK cells from double negative 1 thymocyte precursors. Blood 118:3570-8 |
| Cooper, Megan A; Yokoyama, Wayne M (2010) Memory-like responses of natural killer cells. Immunol Rev 235:297-305 |
| Higuchi, D A; Cahan, P; Gao, J et al. (2010) Structural variation of the mouse natural killer gene complex. Genes Immun 11:637-48 |
Showing the most recent 10 out of 22 publications
